Potassium Binders to Optimize GDMT Therapy in HFrEF
Nihar R. Desai, MD, MPH
Ellie Kelepouris, MD, FACP, FAHA
The Edema Question: Selecting a Potassium Binder in Patients With HF or Congestion
Pauline A. Swift, PhD
CKD, Diabetes, and Albuminuria: Keeping Kidney-Protective Therapy on Board Despite Hyperkalemia
The Binder Selection Playbook: Matching the Right Strategy to the Right Patient
James Burton, DM, FRCP
Personalized Treatment Strategies for Hyperkalemia: Bridging Evidence and Clinical Practice Needs
The Potassium Shift: Individualizing Hyperkalemia Management With Modern Oral Potassium Binders
Differentiating Oral Potassium Binders: Mechanism, Onset, and Sodium Load
From Lab Alert to Action Plan: Monitoring Potassium Without Undermining Cardiorenal Protection
Hyperkalemia as a Barrier to GDMT: Why “Stopping GDMT” Is Often the Wrong Reflex
Rethinking PH-ILD: What Emerging Data Could Mean for Patient Care
Jean M. Elwing, MD, FCCP
Treating Methamphetamine-Associated PAH: The Missing Piece in Patient Care
John Kingrey, MD
AI in Point-of-Care Ultrasound: Balancing Innovation With Clinical Judgment
Taro Minami, MD, FCCP
Recognizing Pulmonary Hypertension in Interstitial Lung Disease
Don’t Miss the Opportunity to Address Persistent CV Risk: Optimizing Outcomes for Ambulatory Patients With HFrEF and LVEF <45%
Robert J. Mentz, MD, FHFSA, FACC
Moving the Needle in oHCM: The Era of Cardiac Myosin Inhibitors
Nosheen Reza, MD
Anjali Tiku Owens, MD
Pieter Martens, MD, MSc, PhD
Translating Evidence Into Practice: Myosin Inhibition Across the HCM Spectrum
Christian Schulze, MD, PhD
Ahmad Masri, MD, MS
Michelle Michels, MD
Loading...
NEW FEATURES:
Tell us what you think by using our Feedback button
We're glad to see you're enjoying Global Cardiology Academy… but how about a more personalized experience?
Press cancel to remain on Global Cardiology Academy. Press the link below or the continue button to keep going.